Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
Code | CSB-MP836195HU |
Abbreviation | Recombinant Human ZG16B protein (Active) |
MSDS | |
Size | $138 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
This Human ZG16B recombinant protein was produced in mammalian cell, where the gene sequence encoding Human ZG16B (53-208aa) was expressed with the C-terminal 10xHis tag. The purity of this ZG16B protein was greater than 95% by SDS-PAGE. The activity was validated in functional ELISA.
ZG16B was first found to be highly expressed in pancreatic cancer and plays an important role in carcinogenesis, and was named as pancreatic cancer-related up-regulator PAUF. The latest research results show that ZG16B plays its role as an oncogene by up-regulating the expression and transcriptional activity of β-catenin in pancreatic cancer. At the same time, other studies have also found that ZG16B is not only highly expressed in pancreatic cancer, but also in colon cancer. It is also highly expressed in ovarian cancer, gastric cancer and other cancer tissues. Furthermore, ZG16B plays an important role in cancer progression such as cell proliferation, adhesion, migration, and invasion. However, in colon cancer, whether ZG16B plays a role in cancer by upregulating the expression and transcriptional activity of β-catenin and activating the Wnt/β-catenin signaling pathway is still unknown. As a novel activator of human endothelial cells, ZG16B has similar effects to vascular endothelial growth factor (VEGF), which can promote angiogenesis and increase vascular permeability in vitro and in vivo.There are currently no reviews for this product.